---
title: Clotrimazole + Metronidazole
description: >-
  Clotrimazole + Metronidazole is prescribed for the treatment of vulvovaginal
  candidiasis (yeast infection) and bacterial vaginosis, often caused by
  *Gardnerella vaginalis* or *Trichomonas vaginalis*.  This combination
  medication addresses mixed vaginal infections where both fungal and bacterial
  p...
is_banned: false
lastModified: '2025-09-22T17:22:08.877Z'
faqs:
  - q: >-
      What is the recommended dosage for Clotrimazole + Metronidazole?**


      **A:**  The usual dose is one vaginal pessary/tablet/applicatorful
      (containing both medications) inserted high into the vagina once daily,
      typically at bedtime, for 6 to 8 days.  The exact formulation, dosage, and
      duration may vary based on the specific product.
    a: >-
      A:**  The usual dose is one vaginal pessary/tablet/applicatorful
      (containing both medications) inserted high into the vagina once daily,
      typically at bedtime, for 6 to 8 days.  The exact formulation, dosage, and
      duration may vary based on the specific product.
  - q: >-
      Can this combination be used during pregnancy?**


      **A:**  Oral Metronidazole should be avoided in the first trimester. Its
      use during other trimesters requires careful risk-benefit assessment.
      Topical Clotrimazole is generally considered safe during pregnancy.
    a: >-
      A:**  Oral Metronidazole should be avoided in the first trimester. Its use
      during other trimesters requires careful risk-benefit assessment. Topical
      Clotrimazole is generally considered safe during pregnancy.
  - q: >-
      What are the common side effects?**


      **A:**  Common side effects include vaginal burning, itching, irritation,
      and headache.  Oral Metronidazole can cause a metallic taste and nausea.
    a: >-
      A:**  Common side effects include vaginal burning, itching, irritation,
      and headache.  Oral Metronidazole can cause a metallic taste and nausea.
  - q: >-
      Are there any drug interactions I should be aware of?**


      **A:** Metronidazole interacts with alcohol, warfarin, lithium, and
      disulfiram. Oral clotrimazole (troches), but not typically the vaginally
      administered form, can interact with drugs metabolized by CYP3A4.
    a: >-
      A:** Metronidazole interacts with alcohol, warfarin, lithium, and
      disulfiram. Oral clotrimazole (troches), but not typically the vaginally
      administered form, can interact with drugs metabolized by CYP3A4.
  - q: >-
      How does this combination work against mixed vaginal infections?**


      **A:**  Clotrimazole targets fungal infections, while Metronidazole covers
      bacterial and protozoal infections, providing broad-spectrum coverage.
    a: >-
      A:**  Clotrimazole targets fungal infections, while Metronidazole covers
      bacterial and protozoal infections, providing broad-spectrum coverage.
  - q: >-
      Can this combination be used in children?**


      **A:** It is not typically recommended for use in children unless
      specifically indicated and under the supervision of a healthcare provider.
    a: >-
      A:** It is not typically recommended for use in children unless
      specifically indicated and under the supervision of a healthcare provider.
  - q: >-
      What should I advise patients regarding alcohol consumption?**


      **A:** Patients should avoid alcohol consumption during Metronidazole
      treatment and for at least 48 hours after the last dose due to the risk of
      a disulfiram-like reaction.
    a: >-
      A:** Patients should avoid alcohol consumption during Metronidazole
      treatment and for at least 48 hours after the last dose due to the risk of
      a disulfiram-like reaction.
  - q: >-
      How should the medication be administered?**


      **A:** The vaginal pessary/tablet/cream should be inserted high into the
      vagina using the provided applicator or finger, preferably at bedtime.
    a: >-
      A:** The vaginal pessary/tablet/cream should be inserted high into the
      vagina using the provided applicator or finger, preferably at bedtime.
  - q: >-
      What should I do if a patient experiences severe side effects?**


      **A:**  Advise the patient to discontinue the medication immediately and
      seek medical attention.
    a: >-
      A:**  Advise the patient to discontinue the medication immediately and
      seek medical attention.
  - q: >-
      Is there a risk of developing resistance to this combination?**


      **A:** While resistance to Metronidazole can occur, it is less common with
      topical application. Resistance to Clotrimazole is rare in vaginal
      infections.
    a: >-
      A:** While resistance to Metronidazole can occur, it is less common with
      topical application. Resistance to Clotrimazole is rare in vaginal
      infections.
---
## **Usage**

Clotrimazole + Metronidazole is prescribed for the treatment of vulvovaginal candidiasis (yeast infection) and bacterial vaginosis, often caused by *Gardnerella vaginalis* or *Trichomonas vaginalis*.  This combination medication addresses mixed vaginal infections where both fungal and bacterial pathogens are present.

- **Pharmacological Classification:**  Clotrimazole is an azole antifungal, and Metronidazole is a nitroimidazole antibiotic with antiprotozoal activity.

- **Mechanism of Action:** Clotrimazole inhibits ergosterol synthesis, a crucial component of fungal cell membranes, leading to fungal cell death. Metronidazole disrupts DNA synthesis and function in susceptible bacteria and protozoa, leading to their demise.

## **Alternate Names**

There isn't a universally recognized alternate name for this specific combination, although the individual components have other names (e.g., Flagyl for Metronidazole).  Several brand names exist depending on the region and manufacturer.

- **Brand Names:** Cloginal, Klovinal are examples of brand names.


## **How It Works**

- **Pharmacodynamics:** Clotrimazole exerts its effect locally in the vagina by disrupting fungal cell membrane integrity. Metronidazole, whether administered orally or vaginally, acts systemically and locally by damaging bacterial and protozoal DNA.  

- **Pharmacokinetics:**  
    - **Clotrimazole:** Topical application results in minimal systemic absorption.
    - **Metronidazole:**  Oral administration yields good absorption. Vaginal administration results in lower serum levels but effective local concentrations.  Metronidazole is metabolized in the liver and excreted primarily through the kidneys.

- **Mode of Action:** Clotrimazole inhibits 14-alpha-demethylase, an enzyme needed for ergosterol synthesis. Metronidazole enters the microbial cell, where it is reduced, forming cytotoxic metabolites that damage DNA.

- **Elimination Pathways:** Primarily renal excretion for Metronidazole after hepatic metabolism;  minimal systemic absorption for topical Clotrimazole.


## **Dosage**

### **Standard Dosage**

#### **Adults:**

One vaginal pessary/tablet/applicatorful (containing Clotrimazole 100mg-500mg and Metronidazole 500mg) inserted high into the vagina daily, usually at bedtime, for 6 to 8 consecutive days. Alternative regimens might involve different dosages and durations depending on the product formulation.

#### **Children:**

Use in children is generally not recommended unless specifically indicated and under the supervision of a healthcare professional.


#### **Special Cases:**

- **Elderly Patients:** Generally well-tolerated, but caution is advised, especially with higher doses of Metronidazole.
- **Patients with Renal Impairment:** Careful consideration is necessary, especially with prolonged courses of systemic Metronidazole. Dose adjustments may be required based on the degree of impairment.
- **Patients with Hepatic Dysfunction:** Dose modifications may be needed for Metronidazole due to altered metabolism.
- **Patients with Comorbid Conditions:** Careful evaluation is essential.

### **Clinical Use Cases**

The combination is primarily used in outpatient settings for vaginal infections. Its use in settings like intubation, surgery, mechanical ventilation, ICU, or emergencies is not indicated.


### **Dosage Adjustments:**

Dose modifications might be necessary in cases of hepatic or renal impairment based on the severity.

## **Side Effects**

### **Common Side Effects**

- Vaginal burning
- Itching or irritation
- Mild headache
- Metallic taste (with oral Metronidazole)
- Nausea (with oral Metronidazole)

### **Rare but Serious Side Effects**

- Severe allergic reactions (rash, swelling, difficulty breathing)
- Peripheral neuropathy (with prolonged high-dose Metronidazole)
- Seizures (with prolonged high-dose Metronidazole)
- Stevens-Johnson Syndrome (rare)

### **Long-Term Effects:**

Long-term effects are uncommon with typical usage.  Peripheral neuropathy can occur with prolonged high doses of Metronidazole.


### **Adverse Drug Reactions (ADR)**

Clinically significant ADRs require prompt cessation of treatment and medical evaluation.

## **Contraindications**

- Hypersensitivity to Clotrimazole or Metronidazole.
- First trimester of pregnancy (especially oral Metronidazole).
- Certain blood disorders (for Metronidazole).
- Active central nervous system diseases (for Metronidazole).
- Use with disulfiram (for Metronidazole).


## **Drug Interactions**

- **Metronidazole:**
    - Alcohol (disulfiram-like reaction)
    - Warfarin (enhanced anticoagulant effect)
    - Lithium (increased lithium levels)
    - Disulfiram
    - Cimetidine

- **Clotrimazole (oral troches):**  CYP3A4 inhibitor, potentially increasing levels of drugs metabolized by this enzyme. Topical clotrimazole is minimally absorbed systemically, so these interactions are less relevant with vaginal use.



## **Pregnancy and Breastfeeding**

- **Pregnancy:** Oral Metronidazole should be avoided during the first trimester.  Use during other trimesters and breastfeeding requires a careful assessment of risks and benefits.  Topical Clotrimazole is generally considered safe during pregnancy and breastfeeding.
- **Breastfeeding:** Metronidazole enters breast milk;  short courses are generally considered compatible with breastfeeding but monitoring for effects in infants is advised.


## **Drug Profile Summary**

- **Mechanism of Action:** Clotrimazole: Inhibits ergosterol synthesis; Metronidazole: Disrupts DNA synthesis.
- **Side Effects:** Vaginal irritation, headache, metallic taste, nausea (Metronidazole).
- **Contraindications:** Hypersensitivity, first trimester of pregnancy (oral Metronidazole), disulfiram use.
- **Drug Interactions:**  Alcohol, warfarin, lithium (Metronidazole); CYP3A4 substrates (oral Clotrimazole).
- **Pregnancy & Breastfeeding:** Use with caution, benefits must outweigh risks.
- **Dosage:** Vaginal application for 6-8 days.
- **Monitoring Parameters:**  Resolution of symptoms, adverse events.


## **Popular Combinations**

Clotrimazole + Metronidazole is itself a common combination.  Sometimes, it might be combined with other drugs for treating BV, like Clindamycin.


## **Precautions**

- Rule out hypersensitivity before use.
- Alcohol avoidance during Metronidazole use.
- Liver and kidney function monitoring, if necessary.
- Advise on potential drug interactions.


## **FAQs (Frequently Asked Questions)**

### **Q1: What is the recommended dosage for Clotrimazole + Metronidazole?**

**A:**  The usual dose is one vaginal pessary/tablet/applicatorful (containing both medications) inserted high into the vagina once daily, typically at bedtime, for 6 to 8 days.  The exact formulation, dosage, and duration may vary based on the specific product.

### **Q2: Can this combination be used during pregnancy?**

**A:**  Oral Metronidazole should be avoided in the first trimester. Its use during other trimesters requires careful risk-benefit assessment. Topical Clotrimazole is generally considered safe during pregnancy.

### **Q3: What are the common side effects?**

**A:**  Common side effects include vaginal burning, itching, irritation, and headache.  Oral Metronidazole can cause a metallic taste and nausea.

### **Q4: Are there any drug interactions I should be aware of?**

**A:** Metronidazole interacts with alcohol, warfarin, lithium, and disulfiram. Oral clotrimazole (troches), but not typically the vaginally administered form, can interact with drugs metabolized by CYP3A4.

### **Q5: How does this combination work against mixed vaginal infections?**

**A:**  Clotrimazole targets fungal infections, while Metronidazole covers bacterial and protozoal infections, providing broad-spectrum coverage.

### **Q6: Can this combination be used in children?**

**A:** It is not typically recommended for use in children unless specifically indicated and under the supervision of a healthcare provider.

### **Q7: What should I advise patients regarding alcohol consumption?**

**A:** Patients should avoid alcohol consumption during Metronidazole treatment and for at least 48 hours after the last dose due to the risk of a disulfiram-like reaction.

### **Q8: How should the medication be administered?**

**A:** The vaginal pessary/tablet/cream should be inserted high into the vagina using the provided applicator or finger, preferably at bedtime.

### **Q9: What should I do if a patient experiences severe side effects?**

**A:**  Advise the patient to discontinue the medication immediately and seek medical attention.


### **Q10: Is there a risk of developing resistance to this combination?**

**A:** While resistance to Metronidazole can occur, it is less common with topical application. Resistance to Clotrimazole is rare in vaginal infections.  




